Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global contrast injectors market since 2015 and the market is poised to grow by USD 613.47 million during 2020-2024, progressing at a CAGR of ...
LONDON--(BUSINESS WIRE)--Technavio market research analysts forecast the global contrast injectors market to grow at a CAGR of around 5% during the period 2018-2022, according to their latest report.
AJR: resources required to warm iohexol 350 to body temperature before injection for CT may not be warranted, given lack of observed practical benefit “The data suggest that maintaining iohexol 350 at ...
The use of automated contrast injector systems during percutaneous coronary intervention (PCI) does not appear to curb kidney damage compared with manual injection, according to an analysis published ...
LOS ANGELES - 4DMedical announced Thursday it has received FDA 510(k) clearance for CT:VQ, a technology that converts standard non-contrast chest CT scans into quantitative ventilation and perfusion ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback